Provided by Tiger Trade Technology Pte. Ltd.

OS Therapies

1.64
+0.04002.50%
Volume:225.23K
Turnover:362.56K
Market Cap:76.21M
PE:-1.56
High:1.65
Open:1.63
Low:1.56
Close:1.60
52wk High:2.25
52wk Low:1.15
Shares:46.47M
Float Shares:33.71M
Volume Ratio:0.78
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0524
EPS(LYR):-0.9829
ROE:-914.04%
ROA:-232.65%
PB:-6.40
PE(LYR):-1.67

Loading ...

Os Therapies - to Issue Senior Secured Convertible Notes up to $10 Mln in Private Placement - SEC Filing

THOMSON REUTERS
·
Aug 13

Os Therapies - Co & Its Wholly Owned Subsidiaries Entered Securities Purchase Agreement on August 10, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 13

OS Therapies Prices up to $10 Million Senior Secured Convertible Note Private Placement

Reuters
·
Aug 13

OS Therapies Agrees to Repay Leonite Debt in USD 1.9 Million Cash Settlement

Reuters
·
Aug 07

OS Therapies - Terminates at Market Issuance Sales Agreement on July 23, 2026 - SEC Filing

Reuters
·
Jul 30

OS Therapies Ends At-The-Market Equity Sales Program

TIPRANKS
·
Jul 30

Os Therapies - Termination of Sales Agreement Effective July 28, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 30

OS Therapies Announces Annual Shareholder Meeting

Reuters
·
Jul 25

OS Therapies Files Form 3 Showing Director Craig Eagle Holds no Securities

Reuters
·
Jul 24

OS Therapies Initiated at Buy by Roth Capital

Dow Jones
·
Jul 09

OS Therapies initiated with a Buy at Roth Capital

TIPRANKS
·
Jul 09

OS Therapies Accepts FDA CDER Meeting Request to Review Ost-her2 Biomarker Data

Reuters
·
Jul 08

OS Therapies Amends 8-K to Add Side Letter Tied to Leonite Private Placement

Reuters
·
Jul 07

OS Therapies Incorporated (OSTX) Gets a Buy from Lake Street

TIPRANKS
·
Jul 07

OS Therapies Enters USD 10 Million Line of Credit Backed by U.K. VAT, R&D Tax Credits

Reuters
·
Jul 06

OS Therapies Secures Convertible Note Financing for Expansion

TIPRANKS
·
Jul 03

Os Therapies - Enters Agreement for up to $10 Mln Senior Secured Convertible Note on June 30- SEC Filing

THOMSON REUTERS
·
Jul 03

OS Therapies Names Chief Medical Advisor Craig Eagle to Board

Reuters
·
Jul 02

OS Therapies Seeks FDA Alignment on 3-year Overall Survival Endpoint for Ost-her2 Accelerated Approval Bid

Reuters
·
Jun 30

OS Therapies Unit OS Animal Health Posts Peer-reviewed Data for Ost-her2 in Canine Osteosarcoma Trial

Reuters
·
Jun 26